Antidepressant response and the serotonin transporter gene-linked polymorphic region
about
From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatmentGenetic prediction of antidepressant drug response and nonresponse in Korean patientsGenetic Role of BDNF Val66Met and 5-HTTLPR Polymorphisms on Depressive DisorderMechanisms underlying the antidepressant response and treatment resistance.Pharmacogenomics and personalized medicine in neuropsychiatry.Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.Pharmacogenetics of antidepressantsGenome-wide association studies of antidepressant outcome: a brief review.Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.Serotonin transporter genotype differentially modulates neural responses to emotional words following tryptophan depletion in patients recovered from depression and healthy volunteers.Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response.Genetic Moderators of the Impact of Physical Activity on Depressive Symptoms.Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depressionSystematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatmentSerotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder.Pharmacogenomics in psychiatry: the relevance of receptor and transporter polymorphisms.The genetic blueprint of major depressive disorder: contributions of imaging genetics studies.Pharmacogenetics in psychiatry: translating research into clinical practice.Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.CB1 receptor antagonists: new discoveries leading to new perspectives.Stress-related depression: neuroendocrine, genetic, and therapeutical aspects.Do we need pharmacogenetics to personalize antidepressant therapy?Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Pharmacogenetics of mood disorders: what clinicians need to know.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Towards personalized treatment of depression: a candidate gene approach.Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines.Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants.Pharmacogenetics and Imaging-Pharmacogenetics of Antidepressant Response: Towards Translational Strategies.The serotonin transporter gene and depression.Genome-wide expression profiling of human lymphoblastoid cell lines identifies CHL1 as a putative SSRI antidepressant response biomarker.Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients.Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.Poststroke depression and 5-HTTLPR.Effects of antidepressant drug exposure on gene expression in the developing cerebral cortex.Interaction between polymorphisms in serotonin transporter (SLC6A4) and serotonin receptor 2A (HTR2A) genes predict treatment response to venlafaxine XR in generalized anxiety disorder.Association of 5-HTTLPR Polymorphism with the Nursing Diagnoses and the Achievement of Nursing Outcomes in Patients with Major Depression.Whole-exome sequencing identifies a polymorphism in the BMP5 gene associated with SSRI treatment response in major depression.
P2860
Q27015830-BDBD991A-577D-4AA8-8E21-720CE4576C8AQ28543005-C1A05E95-4357-4DBD-AC19-8344FDCD00DFQ33620401-2EE397C8-AEF4-4CB2-9509-093BE90FC376Q33814386-B52A5F85-9891-4F2F-A071-9F0FF3DCDAC3Q34280025-857F3117-C853-4DB1-94F5-5241109F245AQ34316695-DEE1705B-5F01-46D5-8E1C-96C1F4B076AFQ34473840-0F0A60F5-EDAA-4C4E-BF50-DF858D31A85BQ35026088-13593751-507D-4F56-B730-C0870E9B8884Q35074796-A2248F0F-7685-4FB3-AAC9-2719F20002E6Q36367301-89F18EEF-9825-45AE-BF0F-0E4368BEDF2DQ36422806-EF98AE6B-51C1-476E-BB48-845ED6936067Q36618462-DCF99B87-99C6-4FFB-A49F-DCA414C97DC5Q36973699-C805C6D4-25B3-44B4-8F64-8ACFBD1431F6Q36998887-F5091C1D-70A0-44CC-88DA-618BF47FC43EQ37206381-07F388D9-46A2-4077-BE55-F342A149F4C9Q37217494-C7C80D87-94AC-4480-817E-401833CA0DC1Q37229060-0F11D1EA-5754-4332-926C-43CFB2D6A22DQ37678047-F47453C7-5DB9-42FC-BBD9-A698246087C5Q37914871-5A0D6611-443F-4761-9404-1DABE36483ADQ37956206-4CE113C3-7428-472A-90E5-CD044C623639Q37989490-558813F4-DA16-41B7-B140-F361C451FF97Q37998561-1C0C3EFA-7B83-4868-85B8-BDC700746607Q38016982-B9E83811-2AF5-4E63-8DFB-C9F108842895Q38070163-21BBCDEB-8AF9-40AA-8630-F7486747723FQ38121519-591FD690-A7A2-4786-A3AD-CCA039B6F219Q38139479-44D2DF8A-C10F-4ADC-80D4-10B935423A76Q38154911-573A46F8-D914-4F0E-81AA-B9F8375AE679Q38208036-4AAF1292-E86D-438E-BF2A-C0ED7AA2DAD3Q38476909-F488A878-3EE2-4C67-A259-BBC1E9A1E0BFQ38606623-63B91722-2664-4B75-8B51-385E12F26370Q38983579-BF947A8D-A6F1-4DA2-8154-0FA99AE4DC0EQ39528924-CE9B6F2F-2384-4193-AFB8-C6F514EBA9FAQ39589817-A7FCD71E-8824-4F05-B45E-BAB2D086EE6BQ41270351-4DF14547-6378-4522-8E72-368BB04D9810Q44220312-8CD1912E-4CA0-48EB-9E19-143334399E2EQ45987544-93190EA9-50C3-4967-9E16-C95C2382D694Q46011308-B106804A-3DC3-4C49-A892-3C277156EA91Q46821332-59BBA8E1-F233-47BD-B210-9154B83C0B39Q47744358-5BDBFAF6-5925-48AE-962E-C4089D0CFA6EQ47830777-5EC5E715-E5E2-4340-B976-B028FA00CC70
P2860
Antidepressant response and the serotonin transporter gene-linked polymorphic region
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@ast
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@en
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@nl
type
label
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@ast
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@en
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@nl
prefLabel
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@ast
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@en
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@nl
P2093
P2860
P1476
Antidepressant response and the serotonin transporter gene-linked polymorphic region
@en
P2093
Matthew J Taylor
Srijan Sen
Zubin Bhagwagar
P2860
P304
P356
10.1016/J.BIOPSYCH.2010.04.034
P407
P577
2010-07-07T00:00:00Z